Sisvel Announces the Launch of the DVB-S2X Patent Pool
At IBC today, Sisvel announced the launch of a new joint patent licensing program, or patent pool, offering a license under patents essential to the DVB-S2X standard, an extension of the DVB-S2 specification that provides additional technologies and features. The program has been launched with a portfolio of essential patents owned or controlled by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V., Hughes Network Systems, LLC, Newtec Cy N.V., RAI - Radiotelevisione Italiana S.p.A., The European Space Agency and WORK Microwave GmbH.
Further information about the terms and conditions of Sisvel’s DVB-S2X licenses is available at http://www.sisvel.com/licensing-programs/digital-video-display-technology/dvb-S2X/license-terms or from Sisvel upon request by companies currently requiring a license.
You may contact Sisvel at the following e-mail address: DVB-S2X@sisvel.com.
The portfolio license makes essential DVB-S2X patents more easily accessible and ensures that all users of this technology will benefit from the transparency and the convenience of the license terms available under this new program.
Davide Ferri, CEO of Sisvel Spa and Sisvel Technology, said “Sisvel and the patent owners have made a consistent effort to launch the DVB-S2X licensing program at this early stage of the technology adoption, thus providing the market with certainty and predictability for the cost of a license. We are therefore very proud of this remarkable achievement”.
Mattia Fogliacco, CEO of the Sisvel Group, said “The EU Commission, in its communication of the 29th of November 2017 setting out the approach to Standard Essential Patents, clearly expressed its support for patent pools and licensing platforms, as being able to ‘address many of the SEP licensing challenges by offering better scrutiny on essentiality, more clarity on aggregate licensing fees and one-stop- shop solutions’. Sisvel is fully aligned with this statement and is confident that this new program will promote a rapid adoption of the DVB-S2X standard”.
The joint DVB-S2X licensing program remains open to additional patent owners, and Sisvel invites all parties with patents believed to be essential to the DVB-S2X standard to contact Sisvel and submit those patent(s) for an evaluation of essentiality by the program’s designated, independent evaluator.
DVB-S2X is a technical standard developed by the DVB Project and adopted by the European Telecommunications Standardization Institute (“ETSI”) as formally specified in the ETSI document EN 302 307 Part 2, with DVB-S2 being part 1. DVB-S2X is an extension of the DVB-S2 specification and offers improved performance and features for the core applications of DVB-S2, including Direct to Home (DTH), contribution, VSAT and DSNG.
For additional technical information relating to the DVB-S2X standard, visit: www.dvb.org.
Sisvel is a world leader in fostering innovation and managing intellectual property. The Group identifies, evaluates and maximizes the value of IP assets for its partners around the world, providing firms with a revenue stream which can be reinvested in innovation for the generation of future revenues. Founded in 1982, the Group is headquartered in Luxembourg and has subsidiaries in China, Germany, Italy, Japan, the United States and the United Kingdom.
Sisvel has a long history of managing successful patent portfolios including those related to the audio compression standards known as MP3 and MPEG Audio, as well as broadcasting and receiving of digital terrestrial television standards maintained by the DVB Project. Sisvel currently operates patent pools and joint licensing programs in the fields of mobile communication, Sisvel Mobile Communication Program; wireless local area networking 802.11, Sisvel 802.11 Wi-Fi Joint Licensing Program; digital video broadcasting, Sisvel DVB-T2 Joint Licensing Program; recommendation engines, Sisvel Recommendation Engine Licensing Program; and broadband access to data networks, Sisvel DSL Licensing Program.
For additional information, please visit: www.sisvel.com.
Giulia Dini, +44 203 053 6930
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Grand Prize Winner in $1.75M Water Abundance XPRIZE Announced at XPRIZE Visioneering 201822.10.2018 17:49 | Pressemelding
During Visioneering 2018, XPRIZE’s annual gathering of philanthropists and innovators to evaluate concepts for future competitions, the Foundation revealed the results of its latest, completed XPRIZE. The Skysource / Skywater Alliance was announced as the grand prize winner of the $1.75M Water Abundance XPRIZE, a two-year competition aimed at alleviating the global water crisis with energy-efficient technologies that harvest fresh water from thin air. In addition at Visioneering, five new prize concepts were evaluated with top honors going to a prize concept called “Coral Survival”, a prize designed to protect and restore coral reefs. This prize will move forward into the XPRIZE pipeline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181022005795/en/ The Skysource / Skywater Alliance team, based in Venice Beach, California, wins the Water Abundance XPRIZE (Photo: Business Wire) The Water Abundance XPRIZE, powered by the Tat
Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 17:15 | Pressemelding
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin
First Data Polska Deploys Inside Secure’s Mobile Payment Technology To Securely and Easily Connect to Mastercard and Visa22.10.2018 15:36 | Pressemelding
Regulatory News: Inside Secure (Paris:INSD) (Euronext Paris: INSD), at the heart of security solutions for mobile and connected devices, today announced that First Data Polska S.A., a division of the global leader in commerce-enabling technology, selected Inside Secure technology to enable secure and flexible connections to Mastercard and Visa. First Data Polska S.A. chose Inside Secure’s Mobile Payment Client to easily integrate their solution with the Visa Token Service (VTS) and Mastercard Digital Enablement Service (MDES) – today’s major tokenization services that convert sensitive data into unique tokens that allow mobile payments to be processed. “Security and reliability are continual requirements for our services,” said Jolanta Rycerz, Member of Management Board at First Data Polska S.A. “We see Inside Secure as a valuable technology provider that enables us to easily migrate to the latest mobile payment technology and security standards. Thanks to Inside Secure, our customers,
PMI Launches Search for Next President and CEO22.10.2018 14:00 | Pressemelding
Project Management Institute (PMI), the world’s leading professional membership organization for project managers, announced today that it has retained Heidrick & Struggles to help the organization find its next President and Chief Executive Officer (CEO). The dynamic leader shall oversee the implementation of a new strategic plan and guide the organization toward a future designed to help thousands of project professionals around the world accelerate their careers and make ideas a reality. Heidrick & Struggles is a premier provider of executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services globally. PMI will conduct a comprehensive global review of both internal and external candidates for this key position. The selected candidate will embody PMI’s core values and possess the skillsets necessary to advance the organization’s key goals. PMI’s next President and CEO will help it execute a bold new multi-year initiative d
E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 13:43 | Pressemelding
E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t
Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 12:00 | Pressemelding
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t